LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Revenue

LENZ Therapeutics had revenue of $5.49M in the quarter ending June 30, 2026, with 9.72% growth. This brings the company's total for the last twelve months to $21.48M, up 329.50% year-over-year. In the year 2025, LENZ Therapeutics had annual revenue of $19.09M. That makes LENZ Therapeutics the 33,377th largest company in the world by revenue and 4,388th in the United States.

• Revenue (ttm): $21.48M
• Revenue Growth: +329.50%
• P/S Ratio: 4.67
• Revenue / Employee: $141,283
• Employees: 152
• Market Cap: 100.23M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.09M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	15.00M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error